Avalo Therapeutics, Inc. (AVTX)
7.30
-0.02
(-0.27%)
USD |
NASDAQ |
Nov 03, 11:43
Avalo Therapeutics Market Cap : 386.18M for Nov. 3, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 02, 2026 | 387.23M |
| October 30, 2026 | 379.30M |
| October 29, 2026 | 393.58M |
| October 28, 2026 | 376.65M |
| October 27, 2026 | 357.08M |
| October 26, 2026 | 358.14M |
| October 23, 2026 | 366.60M |
| October 22, 2026 | 394.11M |
| October 21, 2026 | 648.56M |
| October 20, 2026 | 653.85M |
| October 19, 2026 | 613.12M |
| October 16, 2026 | 596.19M |
| October 15, 2026 | 635.34M |
| October 14, 2026 | 626.34M |
| October 13, 2026 | 635.34M |
| October 12, 2026 | 700.41M |
| October 09, 2026 | 722.09M |
| October 08, 2026 | 710.46M |
| October 07, 2026 | 718.39M |
| October 06, 2026 | 718.92M |
| October 05, 2026 | 772.35M |
| October 02, 2026 | 792.98M |
| October 01, 2026 | 790.87M |
| September 30, 2026 | 810.97M |
| September 29, 2026 | 824.19M |
| Date | Value |
|---|---|
| September 28, 2026 | 797.74M |
| September 25, 2026 | 818.37M |
| September 24, 2026 | 831.60M |
| September 23, 2026 | 809.38M |
| September 22, 2026 | 873.39M |
| September 21, 2026 | 855.40M |
| September 18, 2026 | 876.56M |
| September 17, 2026 | 882.91M |
| September 16, 2026 | 877.09M |
| September 15, 2026 | 850.11M |
| September 14, 2026 | 855.93M |
| September 11, 2026 | 852.76M |
| September 10, 2026 | 908.83M |
| September 09, 2026 | 963.32M |
| September 08, 2026 | 1.043B |
| September 04, 2026 | 1.017B |
| September 03, 2026 | 1.005B |
| September 02, 2026 | 1.023B |
| September 01, 2026 | 1.002B |
| August 31, 2026 | 1.023B |
| August 28, 2026 | 1.036B |
| August 27, 2026 | 1.061B |
| August 26, 2026 | 1.087B |
| August 25, 2026 | 1.044B |
| August 24, 2026 | 1.019B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 510.24B |
| ACADIA Pharmaceuticals, Inc. | 3.573B |
| Alnylam Pharmaceuticals, Inc. | 21.36B |
| Anika Therapeutics, Inc. | 257.89M |
| Savara, Inc. | 977.70M |
Market Cap Related Metrics
| PS Ratio | 2976.36 |
| Price to Book Value | 0.8607 |
| Price | 7.30 |
| Earnings Yield | -64.91% |